Answers are grounded in this paper and cite their sources.
Macrocyclic peptides are promising modalities for metalloprotein inhibition, yet candidates identified via combinatorial display platforms often require post‐selection chemical modification to introduce metal‐chelating groups for optimal potency. Here, we report two C 2v symmetry stapling linkers featuring an integrated hydroxamic acid handle and dual thiol‐reactive groups for the macrocyclization of genetically encoded peptides. Although the 2,3‐dibromomaleimide derivative showed high aqueous solubility and reactivity, it underwent severe degradation that compromised the hydroxamic acid functionality. In contrast, the 1,3‐ bis (bromomethyl)benzene derivative exhibited significantly greater stability. Chromatographic and mass spectrometry‐based kinetic analyses revealed that bis ‐cysteine peptides undergo rapid, clean, and quantitative macrocyclization to yield a single macrocyclic product, whereas single‐cysteine sequences yield monovalent thioether intermediates alongside a series of macrocyclic side‐products resulting from secondary reactions with less nucleophilic residues, such as lysine amine or serine hydroxyl groups. Inhibition studies on two metalloenzymes with the bis ‐cysteine macrocyclic peptide confirmed that the hydroxamic acid moiety remains fully capable of accessing the active‐site metal to block enzymatic activity. Integrating these metal‐chelating linkers with display technologies and macrocyclic libraries could provide a robust platform to rapidly generate potent, highly specific metalloprotein inhibitors, where the peptide motif acts as a secondary recognition element to enhance selectivity.
No takes yet. Share an insight, caveat, or question.
Bordignon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: